Form 4: CEL-SCI Chief Scientific Officer Boosts Stake with Share Acquisition

Eyal Talor, Chief Scientific Officer of CEL SCI CORP, acquired 1,048 shares of common stock at $2.29 per share, increasing his direct beneficial ownership to 5,548 shares.

Summary

• Eyal Talor, Chief Scientific Officer of CEL SCI CORP, acquired 1,048 shares of the company's common stock.
• The transaction occurred on June 30, 2025, with shares purchased at a price of $2.29 each.
• Following this acquisition, Eyal Talor's direct beneficial ownership in CEL SCI CORP stands at 5,548 shares of common stock.

Sentiment

Score: 7

Explanation: The acquisition of additional shares by a key executive generally indicates confidence in the company's future, though this Form 4 provides limited financial or operational details beyond the transaction itself.

Positives

• Chief Scientific Officer Eyal Talor increased his direct beneficial ownership in CEL SCI CORP by acquiring 1,048 shares, which can signal confidence in the company's future prospects.

Future Outlook

NA

Industry Context

This filing reports an individual insider transaction, which is specific to CEL SCI CORP and its Chief Scientific Officer, Eyal Talor. It does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may interpret the Chief Scientific Officer's share acquisition as a positive signal of management's belief in the company's value and future prospects.

Key Dates

Keywords

CEL SCI CORP, CVM, Eyal Talor, insider acquisition, common stock, beneficial ownership, Form 4